References
- Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy range for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1–9.
- Kaplan MM. Alanine aminotransferase levels: what’s normal. [Editorial]. Ann Intern Med 2002;137:49–51.
- Cohen GA, Goffinet JA, Donabedian RK, Conn HO. Observa-tions on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med 1976;84: 275–80.
- Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency. ClinNephol 1995;43: 405–8.
- Yasada K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, et al. Hypo-aminotransferasemia in patients undergoing longterm hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995;109:1295–300.
- Tietz NW, Wekstein DR, Shuey DF, Brauer GA. A two-year longitudinal reference range study for selected serum enzymes in a population more than 60 years of age. J Am Geriatr Soc 1984; 32:563–70.
- Klauke R, Schmidt E, Lorentz K. Recommendations for carrying out standard ECCLS procedures (1988) for the catalytic concentrations of creatinine kinase, aspartate aminotransferase, alanine amino transferase and gamma-glutamyltransferase at 37 degrees C. Eur J Clin Chem Clin Biochem 1993;31: 901–9.
- Leino A, Impivaara O, Irjala K, Maki J, Peltols O, Jarvisalo J. Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee lor Clinical Laboratory Standards (ECCLS). Scand J Clin Lab Invest 1995;55:243–50.
- Vanderlinde RE. Review of pyridoxal phosphate and the transaminases in liver disease. Ann Clin Lab Sci 1986;16:79–93.
- Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86: 632–6.
- Balcke P, Schmidt P, Zazgornik J, Kopsa H, Deutsch E. Secondary oxalosis in chronic renal insufficiency. Z Urol Nephrol 1982;75:409–14.
- Balcke P. Oxalic acid metabolism in chronic renal failure. Wien Klin Wochenschr 1985;Suppl 160:1–15.
- Edwards P, Rose GA. Metabolism of pyridoxine in mild metabolic hyperoxaluria and primary hyperoxaluria (type 1). Urol Int 1991;47:113–7.
- Sangaletti O, Petrillo M, Porro GB. Urinary oxalate recovery after oral oxalic load: an alternative method to the quantitative determination of stool-fat for the diagnosis of lipid malabsorption. Int Med Res 1989;17:526–31.
- McConnell N, Campbell S, Gillanders I, Rolton H, Danesk B. Risk factors for developing renal stones in inflammatory bowel disease. Br J Urol Int 2002;89:835–41.